Brian Goff
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
Brian M. Goff ist Mitglied des Vorstands von Pathways to College Network und Chief Commercial, Global Operations Officer & EVP bei Alexion Pharmaceuticals, Inc. Zuvor hatte er die Position des Chief Operating Officer & Director bei Neurovance, Inc. inne, war Head-Global Hemophilia Franchise bei Baxter Healthcare Corp., Executive Vice President & President-Hematology bei Baxalta, Inc. und VP, Head-Primary Care & Established medicines bei Novartis Pharmaceuticals Corp. Herr Goff erhielt einen Undergraduate-Abschluss vom Skidmore College und einen MBA von der Wharton School der University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 184.508 ( 0,31 % ) | 5 Mio $ | 31.05.2026 | |
| 09.06.2026 | 32.609 ( 0,02 % ) | 458 809 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 08.08.2022 |
| INTELLIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.06.2024 |
Pathways to College Network | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Geschäftsführer | 21.07.2021 |
| BAXALTA INC | Corporate Officer/Principal | 01.07.2016 |
| IDENIX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 15.05.2012 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pathways to College Network | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen